| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Autumn R Schultz, Sarina Singh, Carolyn E Linek-Rajapaksha, Heather R Goode, Adam J Fusic. A Case of Neuroleptic Malignant Syndrome in the Context of Lithium Toxicity and Aripiprazole Use. Clinical neuropharmacology. 2023-10-24. PMID:37874611. |
considerable evidence, however, has suggested that atypical antipsychotics are associated with nms, including the partial dopamine agonist, aripiprazole. |
2023-10-24 |
2023-11-08 |
Not clear |
| Avijeet S Chopra, Dusica Hadzi Boskovic, Amit Kulkarni, Jeffrey M Cochra. Cost-Effectiveness of Aripiprazole Tablets with Sensor versus Oral Atypical Antipsychotics for the Treatment of Schizophrenia Using a Patient-Level Microsimulation Modeling Approach. ClinicoEconomics and outcomes research : CEOR. vol 15. 2023-05-30. PMID:37252199. |
cost-effectiveness of aripiprazole tablets with sensor versus oral atypical antipsychotics for the treatment of schizophrenia using a patient-level microsimulation modeling approach. |
2023-05-30 |
2023-08-14 |
Not clear |
| Collin Vas, Ayush Jain, Mili Trivedi, Manish Kumar Jha, Sanjay J Mathe. Pharmacotherapy for Treatment-Resistant Depression: Antidepressants and Atypical Antipsychotics. The Psychiatric clinics of North America. vol 46. issue 2. 2023-05-06. PMID:37149344. |
atypical antipsychotics are the most widely studied augmentation agent and aripiprazole, brexpiprazole, cariprazine, quetiapine extended-release, and olanzapine-fluoxetine combination are approved for depression. |
2023-05-06 |
2023-08-14 |
Not clear |
| Manish K Jha, Sanjay J Mathe. Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape. The American journal of psychiatry. vol 180. issue 3. 2023-03-01. PMID:36855876. |
in the absence of a consensus definition of trd, this report takes a broad approach by considering inadequate response to one or more courses of antidepressants and focuses on atypical antipsychotics that are approved by the u.s. food and drug administration for treatment of depression (aripiprazole, brexpiprazole, cariprazine, extended-release quetiapine, and olanzapine-fluoxetine combination). |
2023-03-01 |
2023-08-14 |
Not clear |
| Xuebing Liu, Xianzhi Sun, Lu Li, Kuan Zeng, Yi Li, Yujun Gao, Jun M. Co-prescription of aripiprazole on prolactin levels in long-term hospitalized chronic schizophrenic patients with co-morbid type 2 diabetes: A retrospective clinical study. Frontiers in psychiatry. vol 14. 2023-02-23. PMID:36816406. |
one of the most frequent side effects of atypical antipsychotics is hyperprolactinemia (hprl), and metformin or aripiprazole co-prescription is regarded as an effective therapy option for reducing prolactin (prl) levels. |
2023-02-23 |
2023-08-14 |
Not clear |
| Ahmed M Abdelfattah, Sally A Abuelezz, Nevien Hendawy, Eman A Negm, Salwa Abd El Khalek Nawishy, Ahmed Mohamed Mohamed Khali. Sonic hedgehog pathway as a new target of atypical antipsychotics: Revisiting of amisulpride and aripiprazole effects in a rat model of schizophrenia. Life sciences. 2023-01-17. PMID:36649751. |
sonic hedgehog pathway as a new target of atypical antipsychotics: revisiting of amisulpride and aripiprazole effects in a rat model of schizophrenia. |
2023-01-17 |
2023-08-14 |
rat |
| Victoria A Nazarova, Aleksandr V Sokolov, Vladimir N Chubarev, Vadim V Tarasov, Helgi B Schiöt. Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials. Frontiers in pharmacology. vol 13. 2022-12-05. PMID:36467081. |
several studies investigated antidepressants (e.g., bupropion hydrochloride, vortioxetine), and atypical antipsychotics (e.g., quetiapine, aripiprazole) but these are yet not approved by the fda for adhd treatment. |
2022-12-05 |
2023-08-14 |
Not clear |
| Jaedeok Kim, Nayoung Lee, Sang Bum Suh, Sooyeon Jang, Saeha Kim, Dong-Gyu Kim, Jong Kook Park, Keun-Wook Lee, Soo Young Choi, Chan Hee Le. Metformin ameliorates olanzapine-induced disturbances in POMC neuron number, axonal projection, and hypothalamic leptin resistance. BMB reports. 2022-06-02. PMID:35651327. |
while atypical antipsychotics such as aripiprazole are not associated with obesity and diabetes, olanzapine is still widely used based on the anticipation that it is more effective in treating severe schizophrenia than aripiprazole, despite its metabolic side effects. |
2022-06-02 |
2023-08-13 |
mouse |
| Antonio M Persico, Arianna Ricciardello, Marco Lamberti, Laura Turriziani, Francesca Cucinotta, Claudia Brogna, Benedetto Vitiello, Celso Arang. The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present. Progress in neuro-psychopharmacology & biological psychiatry. vol 110. 2021-11-01. PMID:33857522. |
to date, atypical antipsychotics such as risperidone and aripiprazole represent the first line of intervention for hyperactivity, impulsivity, agitation, temper outbursts or aggression towards self or others. |
2021-11-01 |
2023-08-13 |
Not clear |
| Paula Soria-Chacartegui, Gonzalo Villapalos-García, Pablo Zubiaur, Francisco Abad-Santos, Dora Kolle. Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone. Frontiers in pharmacology. vol 12. 2021-08-03. PMID:34335273. |
olanzapine, aripiprazole and risperidone are atypical antipsychotics or neuroleptics widely used for schizophrenia treatment. |
2021-08-03 |
2023-08-13 |
Not clear |
| Alexander Kiss, Jana Osack. Effect of amisulpride, olanzapine, quetiapine, and aripiprazole single administration on c-Fos expression in vasopressinergic and oxytocinergic neurons of the rat hypothalamic supraoptic nucleus. Endocrine regulations. vol 54. issue 2. 2021-04-02. PMID:32597151. |
the goal of this study was to reveal the impact of four types of atypical antipsychotics including amisulpride (ami), olanzapine (ola), quetiapine (que), and aripiprazole (ari), with different receptor-affinity profile and dissociation constant, on the activity of hypothalamic supraoptic nucleus (son) vasopressinergic and oxytocinergic neurons. |
2021-04-02 |
2023-08-13 |
rat |
| Erik Johnsen, Rune A Kroken, Else-Marie Løberg, Maria Rettenbacher, Inge Joa, Tor Ketil Larsen, Solveig Klæbo Reitan, Berit Walla, Renata Alisauskiene, Liss Gøril Anda, Christoffer Bartz-Johannessen, Jan Øystein Berle, Jill Bjarke, Farivar Fathian, Kenneth Hugdahl, Eirik Kjelby, Igne Sinkeviciute, Silje Skrede, Lena Stabell, Vidar M Steen, W Wolfgang Fleischhacke. Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial. The lancet. Psychiatry. vol 7. issue 11. 2021-01-14. PMID:33069317. |
amisulpride, aripiprazole, and olanzapine are first-line atypical antipsychotics that have not previously been compared head-to-head in a pragmatic trial. |
2021-01-14 |
2023-08-13 |
Not clear |
| Joshua S Frankel, Thomas L Schwart. Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole. Therapeutic advances in psychopharmacology. vol 7. issue 1. 2020-10-01. PMID:28101322. |
brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole. |
2020-10-01 |
2023-08-13 |
Not clear |
| Eiji Kirin. Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics. Annals of general psychiatry. vol 16. 2020-10-01. PMID:29209406. |
serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics. |
2020-10-01 |
2023-08-13 |
Not clear |
| David A Kah. Commentary: Aripiprazole: The Second Wave of the Second-generation Antipsychotics. Journal of psychiatric practice. vol 25. issue 2. 2020-06-19. PMID:30849064. |
aripiprazole was the first of a subgroup of atypical antipsychotics that are mixed agonists and antagonists of dopamine, likely contributing to unusual responses in some patients. |
2020-06-19 |
2023-08-13 |
Not clear |
| P Ratajczak, K Kus, M Skurzyńska, E Nowakowsk. The influence of aripiprazole and venlafaxine on the antidepressant-like effect observed in prenatally stressed rats (animal model of depression). Human & experimental toxicology. vol 37. issue 9. 2018-12-11. PMID:29239218. |
analysis of data from both clinical and experimental studies allows a conclusion that atypical antipsychotics, such as aripiprazole (ari), may also be effective in treating depression in addition to antidepressants. |
2018-12-11 |
2023-08-13 |
rat |
| Akshya Vasudev, Sumit Chaudhari, Rickinder Sethi, Rachel Fu, Rachel M Sandieson, Brent P Foreste. A Review of the Pharmacological and Clinical Profile of Newer Atypical Antipsychotics as Treatments for Bipolar Disorder: Considerations for Use in Older Patients. Drugs & aging. vol 35. issue 10. 2018-12-11. PMID:30187288. |
we conducted a systematic search utilizing the medline, embase, psycinfo and cochrane library electronic databases, with the aim of identifying all rcts comparing newer atypical antipsychotics approved by the us fda since 2002 (including brexpiprazole, cariprazine, lurasidone, iloperidone, asenapine, paliperidone, and aripiprazole) with placebo or another comparator, in the treatment of any phase of bipolar disorder (including mania, depression or mixed episodes while used as an acute or maintenance treatment) in older adults (> 65 years). |
2018-12-11 |
2023-08-13 |
Not clear |
| Naoto Mizumura, Masato Uematsu, Aya Ito, Satoshi Okumura, Hiromitsu Maehira, Masao Ogawa, Masayasu Kawasak. "Brief" Aripiprazole-induced Neuroleptic Malignant Syndrome with Symptoms that Only Lasted a Few Hours. Internal medicine (Tokyo, Japan). vol 56. issue 22. 2018-05-14. PMID:28943586. |
atypical nms usually lacks major symptoms and frequently occurs after treatment using atypical antipsychotics, such as aripiprazole. |
2018-05-14 |
2023-08-13 |
Not clear |
| Young Sup Woo, Won-Myong Bahk, Young-Min Park, Sangkeun Chung, Bo-Hyun Yoon, Seunghee Won, Jeong Goo Lee, Hwang-Bin Lee, Won Kim, Jong-Hyun Jeong, Kwanghun Lee, Moon-Doo Ki. Effects of switching to aripiprazole from current atypical antipsychotics on subsyndromal symptoms and tolerability in patients with bipolar disorder. International clinical psychopharmacology. vol 31. issue 5. 2017-11-27. PMID:27487259. |
effects of switching to aripiprazole from current atypical antipsychotics on subsyndromal symptoms and tolerability in patients with bipolar disorder. |
2017-11-27 |
2023-08-13 |
Not clear |
| Chunsong Yang, Zilong Hao, Cairong Zhu, Qin Guo, Dezhi Mu, Lingli Zhan. Interventions for tic disorders: An overview of systematic reviews and meta analyses. Neuroscience and biobehavioral reviews. vol 63. 2016-12-13. PMID:26751711. |
six srs assessed the efficacy of atypical antipsychotics and indicated that atypical antipsychotics (i.e., risperidone, aripiprazole) could significantly improved tic symptoms compared with placebo or typical antipsychotics with less aes. |
2016-12-13 |
2023-08-13 |
Not clear |